BackCoherus Biosciences Overview

Coherus Biosciences Total Revenue

Revenue analysis for CHRS.

Quarterly Revenue

$12.31M
↑ 61.99% YoY

As of Mar 2026

Annual Revenue (TTM)

$46.88M
↓ 76.26% YoY

Trailing 12 months ending Mar 2026

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin